Bioassay Development for Bispecific Antibodies-Challenges and Opportunities.

Ames C Register, Somayeh S Tarighat, Ho Young Lee

International journal of molecular sciences 2021 May 19

filter terms:

Antibody therapeutics are expanding with promising clinical outcomes, and diverse formats of antibodies are further developed and available for patients of the most challenging disease areas. Bispecific antibodies (BsAbs) have several significant advantages over monospecific antibodies by engaging two antigen targets. Due to the complicated mechanism of action, diverse structural variations, and dual-target binding, developing bioassays and other types of assays to characterize BsAbs is challenging. Developing bioassays for BsAbs requires a good understanding of the mechanism of action of the molecule, principles and applications of different bioanalytical methods, and phase-appropriate considerations per regulatory guidelines. Here, we review recent advances and case studies to provide strategies and insights for bioassay development for different types of bispecific molecules.

Citation

Ames C Register, Somayeh S Tarighat, Ho Young Lee. Bioassay Development for Bispecific Antibodies-Challenges and Opportunities. International journal of molecular sciences. 2021 May 19;22(10)